Correction to: Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52

Correction to: Early adolescent Skills for emotions (EASE) intervention for the treatment of psychological distress in Adolescents: Study protocol for randomised controlled trials in Lebanon and Jordan (Trials (2019) 20 (545) DOI: 10.1186/s13063-019-3654-3)

Brown, Felicity L.
Steen, Frederik
Taha, Karine
Aoun, May
Bryant, Richard A.
Jordans, Mark J.D.
Malik, Aiysha
Van Ommeren, Mark
Abualhaija, Adnan
Aqel, Ibrahim Said
Ghatasheh, Maha
Habashneh, Rand
Sijbrandij, Marit
El Chammay, Rabih
Watts, Sarah
Akhtar, Aemal

October 2019

Following publication of the original article [1], we have been notified that Figure 1 was published...

Correction to: Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial.

Durez, Patrick
Pavelka, Karel
Lazaro, Maria Alicia
Garcia-Kutzbach, Abraham
Moots, Robert J
Amital, Howard
Govoni, Marinella
Vastesaeger, Nathan

January 2018

Correction to: Clinical Rheumatology (2018) 37:1417–1420 (https://doi.org/10.1007/s10067-018-4074-6)...

Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison.

Nash, Peter
McInnes, Iain B
Mease, Philip
Thom, Howard
Hunger, Matthias
Karabis, Andreas
Gandhi, Kunal
Mpofu, Shephard
Jugl, Steffen M

June 2018

Under Methods section, heading Analyses: Pairwise Comparisons, one of the probability value was publ...

Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) (Clinical Rheumatology, (2018), 37, 3, (667-675), 10.1007/s10067-018-3989-2)

Iannone, F
Santo, L
Bucci, R
Semeraro, A
Carlino, G
Paoletti, F
Quarta, L
Leucci, P
Zuccaro, C
Marsico, A
Scioscia, C
D'Onofrio, F
Mazzotta, D
Muratore, M
Cantatore, Fp
Lapadula, G.

January 2018

In Fig. 1 - paned D, incorrect image was published. This is now presented correctly in this art...

Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) (Clinical Rheumatology, (2018), 37, 3, (667-675), 10.1007/s10067-018-3989-2)

Iannone, F.
Santo, L.
Bucci, R.
Semeraro, A.
Carlino, G.
Paoletti, F.
Quarta, L.
Leucci, P.
Zuccaro, C.
Marsico, A.
Scioscia, C.
D'Onofrio, F.
Mazzotta, D.
Muratore, M.
Cantatore, F. P.
Lapadula, G.

January 2018

In Fig. 1 - paned D, incorrect image was published. This is now presented correctly in this article

Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) (Clinical Rheumatology, (2018), 37, 3, (667-675), 10.1007/s10067-018-3989-2)

Iannone F
Santo L
Bucci R
Semeraro A
Carlino G
Paoletti F
Quarta L
Leucci P
Zuccaro C
Marsico A
Scioscia C
D'ONOFRIO, FABIANA
Mazzotta D
Muratore M
Cantatore FP
Lapadula G.

January 2018

In Fig. 1 - paned D, incorrect image was published. This is now presented correctly in this art...

Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) (Clinical Rheumatology, (2018), 37, 3, (667-675), 10.1007/s10067-018-3989-2)

Iannone F.
Santo L.
Bucci R.
Semeraro A.
Carlino G.
Paoletti F.
Quarta L.
Leucci P.
Zuccaro C.
Marsico A.
Scioscia C.
D'Onofrio F.
Mazzotta D.
Muratore M.
Cantatore F. P.
Lapadula G.

January 2018

In Fig. 1 - paned D, incorrect image was published. This is now presented correctly in this article

Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis.

van der Heijde, Désirée
Deodhar, Atul
FitzGerald, Oliver
Fleischmann, Roy
Gladman, Dafna
Gottlieb, Alice B
Hoepken, Bengt
Bauer, Lars
Irvin-Sellers, Oscar
Khraishi, Majed
Peterson, Luke
Turkiewicz, Anthony
Wollenhaupt, Jürgen
Mease, Philip

March 2018

[This corrects the article DOI: 10.1136/rmdopen-2017-000582.][This corrects the article DOI: 10.1136...

Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis.

van der Heijde, Désirée
Deodhar, Atul
FitzGerald, Oliver
Fleischmann, Roy
Gladman, Dafna
Gottlieb, Alice B
Hoepken, Bengt
Bauer, Lars
Irvin-Sellers, Oscar
Khraishi, Majed
Peterson, Luke
Turkiewicz, Anthony
Wollenhaupt, Jürgen
Mease, Philip

March 2018

[This corrects the article DOI: 10.1136/rmdopen-2017-000582.][This corrects the article DOI: 10.1136...

Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.

Walsh, J A
Gottlieb, A B
Hoepken, B
Nurminen, T
Mease, P J

December 2018

The above article originally published with an error present in Discussion section and presented cor...

Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs

Ghosh, Subrata
Gensler, Lianne S
Yang, Zijiang
Gasink, Chris
Chakravarty, Soumya D
Farahi, Kamyar
Ramachandran, Paraneedharan
Ott, Elyssa
Strober, Bruce E

June 2019

In the original publication of this article, the following correction should be noted in Table ...

Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs.

Ghosh, Subrata
Gensler, Lianne S
Yang, Zijiang
Gasink, Chris
Chakravarty, Soumya D
Farahi, Kamyar
Ramachandran, Paraneedharan
Ott, Elyssa
Strober, Bruce E

June 2019

In the original publication of this article, the following correction should be noted in Table ...

Correction To: Proposal For A Simple Algorithm To Differentiate Adult-Onset Still’S Disease With Other Fever Of Unknown Origin Causes: A Longitudinal Prospective Study (Clinical Rheumatology, (2019), 10.1007/S10067-019-04455-Y)

Bilgin, E.
Hayran, M.
Erden, A.
Armağan, B.
Sarı, A.
Kılıç, L.
Akdoğan, A.
Karadağ, Ö.
Bilgen, Ş.A.
Kiraz, S.
Ertenli, İ.
Kalyoncu, U.

January 2019

The author regrets that the original version of this article contained error. Figure 1 was shown in ...

Correction to: Cell adhesion molecules, plasminogen activator inhibitor type 1, and metabolic syndrome in patients with psoriasis (Clinical and Experimental Medicine, (2020), 20, 1, (39-48), 10.1007/s10238-019-00595-2)

G G Teixeira (13516279)
N L Mari (13353855)
J C C de Paula (13516282)
C C de Alcantara (13516285)
T Flauzino (13353441)
M A B Lozovoy (13353399)
L M M Martin (13516288)
E M V Reiche (13353390)
M Maes (13320648)
I Dichi (13353405)
A N C Simão (13353909)

October 2022

The original version of this article unfortunately contained a mistake. Camila Cataldi de Alcantara ...

Correction to: Early adolescent Skills for emotions (EASE) intervention for the treatment of psychological distress in Adolescents: Study protocol for randomised controlled trials in Lebanon and Jordan (Trials (2019) 20 (545) DOI: 10.1186/s13063-019-3654-3)

Brown, Felicity L.
Steen, Frederik
Taha, Karine
Aoun, May
Bryant, Richard A.
Jordans, Mark J.D.
Malik, Aiysha
Van Ommeren, Mark
Abualhaija, Adnan
Aqel, Ibrahim Said
Ghatasheh, Maha
Habashneh, Rand
Sijbrandij, Marit
El Chammay, Rabih
Watts, Sarah
Akhtar, Aemal

October 2019

Following publication of the original article [1], we have been notified that Figure 1 was published...

Correction to: Early adolescent Skills for emotions (EASE) intervention for the treatment of psychological distress in Adolescents: Study protocol for randomised controlled trials in Lebanon and Jordan (Trials (2019) 20 (545) DOI: 10.1186/s13063-019-3654-3)

Brown, Felicity L.
Steen, Frederik
Taha, Karine
Aoun, May
Bryant, Richard A.
Jordans, Mark J.D.
Malik, Aiysha
Van Ommeren, Mark
Abualhaija, Adnan
Aqel, Ibrahim Said
Ghatasheh, Maha
Habashneh, Rand
Sijbrandij, Marit
El Chammay, Rabih
Watts, Sarah
Akhtar, Aemal

October 2019

Following publication of the original article [1], we have been notified that Figure 1 was published...

Correction to: Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial.

Durez, Patrick
Pavelka, Karel
Lazaro, Maria Alicia
Garcia-Kutzbach, Abraham
Moots, Robert J
Amital, Howard
Govoni, Marinella
Vastesaeger, Nathan

January 2018

Correction to: Clinical Rheumatology (2018) 37:1417–1420 (https://doi.org/10.1007/s10067-018-4074-6)...

Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison.

Nash, Peter
McInnes, Iain B
Mease, Philip
Thom, Howard
Hunger, Matthias
Karabis, Andreas
Gandhi, Kunal
Mpofu, Shephard
Jugl, Steffen M

June 2018

Under Methods section, heading Analyses: Pairwise Comparisons, one of the probability value was publ...

Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) (Clinical Rheumatology, (2018), 37, 3, (667-675), 10.1007/s10067-018-3989-2)

Iannone, F
Santo, L
Bucci, R
Semeraro, A
Carlino, G
Paoletti, F
Quarta, L
Leucci, P
Zuccaro, C
Marsico, A
Scioscia, C
D'Onofrio, F
Mazzotta, D
Muratore, M
Cantatore, Fp
Lapadula, G.

January 2018

In Fig. 1 - paned D, incorrect image was published. This is now presented correctly in this art...

Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) (Clinical Rheumatology, (2018), 37, 3, (667-675), 10.1007/s10067-018-3989-2)

Iannone, F.
Santo, L.
Bucci, R.
Semeraro, A.
Carlino, G.
Paoletti, F.
Quarta, L.
Leucci, P.
Zuccaro, C.
Marsico, A.
Scioscia, C.
D'Onofrio, F.
Mazzotta, D.
Muratore, M.
Cantatore, F. P.
Lapadula, G.

January 2018

In Fig. 1 - paned D, incorrect image was published. This is now presented correctly in this article

Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) (Clinical Rheumatology, (2018), 37, 3, (667-675), 10.1007/s10067-018-3989-2)

Iannone F
Santo L
Bucci R
Semeraro A
Carlino G
Paoletti F
Quarta L
Leucci P
Zuccaro C
Marsico A
Scioscia C
D'ONOFRIO, FABIANA
Mazzotta D
Muratore M
Cantatore FP
Lapadula G.

January 2018

In Fig. 1 - paned D, incorrect image was published. This is now presented correctly in this art...

Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) (Clinical Rheumatology, (2018), 37, 3, (667-675), 10.1007/s10067-018-3989-2)

Iannone F.
Santo L.
Bucci R.
Semeraro A.
Carlino G.
Paoletti F.
Quarta L.
Leucci P.
Zuccaro C.
Marsico A.
Scioscia C.
D'Onofrio F.
Mazzotta D.
Muratore M.
Cantatore F. P.
Lapadula G.

January 2018

In Fig. 1 - paned D, incorrect image was published. This is now presented correctly in this article

Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis.

van der Heijde, Désirée
Deodhar, Atul
FitzGerald, Oliver
Fleischmann, Roy
Gladman, Dafna
Gottlieb, Alice B
Hoepken, Bengt
Bauer, Lars
Irvin-Sellers, Oscar
Khraishi, Majed
Peterson, Luke
Turkiewicz, Anthony
Wollenhaupt, Jürgen
Mease, Philip

March 2018

[This corrects the article DOI: 10.1136/rmdopen-2017-000582.][This corrects the article DOI: 10.1136...

Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis.

van der Heijde, Désirée
Deodhar, Atul
FitzGerald, Oliver
Fleischmann, Roy
Gladman, Dafna
Gottlieb, Alice B
Hoepken, Bengt
Bauer, Lars
Irvin-Sellers, Oscar
Khraishi, Majed
Peterson, Luke
Turkiewicz, Anthony
Wollenhaupt, Jürgen
Mease, Philip

March 2018

[This corrects the article DOI: 10.1136/rmdopen-2017-000582.][This corrects the article DOI: 10.1136...

Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.

Walsh, J A
Gottlieb, A B
Hoepken, B
Nurminen, T
Mease, P J

December 2018

The above article originally published with an error present in Discussion section and presented cor...

Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs

Ghosh, Subrata
Gensler, Lianne S
Yang, Zijiang
Gasink, Chris
Chakravarty, Soumya D
Farahi, Kamyar
Ramachandran, Paraneedharan
Ott, Elyssa
Strober, Bruce E

June 2019

In the original publication of this article, the following correction should be noted in Table ...

Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs.

Ghosh, Subrata
Gensler, Lianne S
Yang, Zijiang
Gasink, Chris
Chakravarty, Soumya D
Farahi, Kamyar
Ramachandran, Paraneedharan
Ott, Elyssa
Strober, Bruce E

June 2019

In the original publication of this article, the following correction should be noted in Table ...

Correction To: Proposal For A Simple Algorithm To Differentiate Adult-Onset Still’S Disease With Other Fever Of Unknown Origin Causes: A Longitudinal Prospective Study (Clinical Rheumatology, (2019), 10.1007/S10067-019-04455-Y)

Bilgin, E.
Hayran, M.
Erden, A.
Armağan, B.
Sarı, A.
Kılıç, L.
Akdoğan, A.
Karadağ, Ö.
Bilgen, Ş.A.
Kiraz, S.
Ertenli, İ.
Kalyoncu, U.

January 2019

The author regrets that the original version of this article contained error. Figure 1 was shown in ...

Correction to: Cell adhesion molecules, plasminogen activator inhibitor type 1, and metabolic syndrome in patients with psoriasis (Clinical and Experimental Medicine, (2020), 20, 1, (39-48), 10.1007/s10238-019-00595-2)

G G Teixeira (13516279)
N L Mari (13353855)
J C C de Paula (13516282)
C C de Alcantara (13516285)
T Flauzino (13353441)
M A B Lozovoy (13353399)
L M M Martin (13516288)
E M V Reiche (13353390)
M Maes (13320648)
I Dichi (13353405)
A N C Simão (13353909)

October 2022

The original version of this article unfortunately contained a mistake. Camila Cataldi de Alcantara ...

Correction to: Early adolescent Skills for emotions (EASE) intervention for the treatment of psychological distress in Adolescents: Study protocol for randomised controlled trials in Lebanon and Jordan (Trials (2019) 20 (545) DOI: 10.1186/s13063-019-3654-3)

Brown, Felicity L.
Steen, Frederik
Taha, Karine
Aoun, May
Bryant, Richard A.
Jordans, Mark J.D.
Malik, Aiysha
Van Ommeren, Mark
Abualhaija, Adnan
Aqel, Ibrahim Said
Ghatasheh, Maha
Habashneh, Rand
Sijbrandij, Marit
El Chammay, Rabih
Watts, Sarah
Akhtar, Aemal

October 2019

Following publication of the original article [1], we have been notified that Figure 1 was published...

Correction to: Early adolescent Skills for emotions (EASE) intervention for the treatment of psychological distress in Adolescents: Study protocol for randomised controlled trials in Lebanon and Jordan (Trials (2019) 20 (545) DOI: 10.1186/s13063-019-3654-3)

Brown, Felicity L.
Steen, Frederik
Taha, Karine
Aoun, May
Bryant, Richard A.
Jordans, Mark J.D.
Malik, Aiysha
Van Ommeren, Mark
Abualhaija, Adnan
Aqel, Ibrahim Said
Ghatasheh, Maha
Habashneh, Rand
Sijbrandij, Marit
El Chammay, Rabih
Watts, Sarah
Akhtar, Aemal

October 2019

Following publication of the original article [1], we have been notified that Figure 1 was published...

Correction to: Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial.

Durez, Patrick
Pavelka, Karel
Lazaro, Maria Alicia
Garcia-Kutzbach, Abraham
Moots, Robert J
Amital, Howard
Govoni, Marinella
Vastesaeger, Nathan

January 2018

Correction to: Clinical Rheumatology (2018) 37:1417–1420 (https://doi.org/10.1007/s10067-018-4074-6)...

Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison.

Nash, Peter
McInnes, Iain B
Mease, Philip
Thom, Howard
Hunger, Matthias
Karabis, Andreas
Gandhi, Kunal
Mpofu, Shephard
Jugl, Steffen M

June 2018

Under Methods section, heading Analyses: Pairwise Comparisons, one of the probability value was publ...

Correction to: Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52

Abstract

Extracted data

Correction to: Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52

Abstract

Extracted data

Related items

Related items